Age 0 3 0 3 B-age
greater 4 11 4 11 O
than 12 16 12 16 O
or 17 19 17 19 O
equal 20 25 20 25 O
to 26 28 26 28 O
18 29 31 29 31 B-lower_bound
years 32 37 32 37 I-lower_bound

Atazanavir 0 10 38 48 B-treatment
, 10 11 48 49 O
clarithromycin 12 26 50 64 B-treatment
, 26 27 64 65 O
indinavir 28 37 66 75 B-treatment
, 37 38 75 76 O
itraconazole 39 51 77 89 B-treatment
, 51 52 89 90 O
ketoconazole 53 65 91 103 B-treatment
, 65 66 103 104 O
nefazodone 67 77 105 115 B-treatment
, 77 78 115 116 O
nelfinavir 79 89 117 127 B-treatment
, 89 90 127 128 O
ritonavir 91 100 129 138 B-treatment
, 100 101 138 139 O
saquinavir 102 112 140 150 B-treatment
, 112 113 150 151 O
telithromycin 114 127 152 165 B-treatment
, 127 128 165 166 O
amprenavir 129 139 167 177 B-treatment
, 139 140 177 178 O
aprepitant 141 151 179 189 B-treatment
, 151 152 189 190 O
diltiazem 153 162 191 200 B-treatment
, 162 163 200 201 O
erythromycin 164 176 202 214 B-treatment
, 176 177 214 215 O
fluconazole 178 189 216 227 B-treatment
, 189 190 227 228 O
fosamprenavir 191 204 229 242 B-treatment
, 204 205 242 243 O
grapefruit 206 216 244 254 O
juice 217 222 255 260 O
, 222 223 260 261 O
verapamil 224 233 262 271 B-treatment

Creatinine 0 10 272 282 B-clinical_variable
> 11 12 283 284 O
1.5 13 16 285 288 B-lower_bound
, 16 17 288 289 O
and/or 18 24 290 296 O
estimated 25 34 297 306 O
creatinine 35 45 307 317 B-clinical_variable
clearance 46 55 318 327 I-clinical_variable
less 56 60 328 332 O
than 61 65 333 337 O
30 66 68 338 340 B-upper_bound
mL 69 71 341 343 I-upper_bound
/ 71 72 343 344 I-upper_bound
min 72 75 344 347 I-upper_bound

Cyclosporine 0 12 348 360 B-treatment
, 12 13 360 361 O
ranolazine 14 24 362 372 B-treatment

MUA 0 3 373 376 B-treatment
indicated 4 13 377 386 O
within 14 20 387 393 O
5 21 22 394 395 B-lower_bound
to 23 25 396 398 O
12 26 28 399 401 B-upper_bound
weeks 29 34 402 407 I-upper_bound
of 35 37 408 410 O
primary 38 45 411 418 B-treatment
surgery 46 53 419 426 I-treatment

Non 0 3 427 430 B-language_fluency
- 3 4 430 431 I-language_fluency
English 4 11 431 438 I-language_fluency
speaking 12 20 439 447 I-language_fluency
patients 21 29 448 456 I-language_fluency

Patients 0 8 457 465 O
concurrently 9 21 466 478 O
taking 22 28 479 485 O
medications 29 40 486 497 O
that 41 45 498 502 O
increase 46 54 503 511 O
the 55 58 512 515 O
risk 59 63 516 520 O
for 64 67 521 524 O
myopathy 68 76 525 533 B-chronic_disease
and 77 80 534 537 O
rhabdomyolysis 81 95 538 552 B-chronic_disease

Patients 0 8 553 561 O
requiring 9 18 562 571 O
bilateral 19 28 572 581 B-treatment
MUA 29 32 582 585 I-treatment

Patients 0 8 586 594 O
with 9 13 595 599 O
hepatic 14 21 600 607 B-chronic_disease
disease 22 29 608 615 I-chronic_disease
( 30 31 616 617 O
known 31 36 617 622 O
liver 37 42 623 628 B-chronic_disease
disease 43 50 629 636 I-chronic_disease
, 50 51 636 637 O
cirrhosis 52 61 638 647 B-chronic_disease
, 61 62 647 648 O
and/or 63 69 649 655 O
AST 70 73 656 659 B-clinical_variable
/ 73 74 659 660 I-clinical_variable
ALT>60 74 80 660 666 I-clinical_variable
) 80 81 666 667 O

Patients 0 8 668 676 O
with 9 13 677 681 O
less 14 18 682 686 O
than 19 23 687 691 O
10 24 26 692 694 B-upper_bound
degrees 27 34 695 702 I-upper_bound
of 35 37 703 705 O
a 38 39 706 707 O
flexion 40 47 708 715 B-treatment
contracture 48 59 716 727 I-treatment

Patients 0 8 728 736 O
with 9 13 737 741 O
renal 14 19 742 747 B-chronic_disease
disease 20 27 748 755 I-chronic_disease

Patients 0 8 756 764 O
with 9 13 765 769 O
reported 14 22 770 778 O
allergy 23 30 779 786 O
to 31 33 787 789 O
colchicine 34 44 790 800 B-allergy_name

Pregnant 0 8 801 809 B-pregnancy
patients 9 17 810 818 O

Primary 0 7 819 826 O
Diagnosis 8 17 827 836 O
of 18 20 837 839 O
OA 21 23 840 842 B-chronic_disease
for 24 27 843 846 O
TKA 28 31 847 850 B-treatment

Revision 0 8 851 859 B-treatment
TKA 9 12 860 863 I-treatment

atorvastatin 0 12 864 876 B-treatment
, 12 13 876 877 O
fluvastatin 14 25 878 889 B-treatment
, 25 26 889 890 O
pravastatin 27 38 891 902 B-treatment
, 38 39 902 903 O
simvastatin 40 51 904 915 B-treatment
, 51 52 915 916 O
fibrates 53 61 917 925 B-treatment
, 61 62 925 926 O
gemfibrozil 63 74 927 938 B-treatment
, 74 75 938 939 O
digoxin 76 83 940 947 B-treatment

knee 0 4 948 952 B-clinical_variable
flexion 5 12 953 960 I-clinical_variable
angle 13 18 961 966 I-clinical_variable
less 19 23 967 971 O
than 24 28 972 976 O
90 29 31 977 979 B-upper_bound
Â° 31 32 979 980 I-upper_bound

